Decreased PSA levels in prostate cancer patients may have confounding factors, including the concomitant use of medical therapies, such as hormones, statins and non-steroidal anti-inflammatory drugs, and/or a higher BMI. This evidence concerns the gene KLK3 and Familial prostate cancer.